Top Section/Ad
Top Section/Ad
Most recent
A slow destruction of misallocated investment is more likely than a sudden stop
LBO financing includes $5.75bn term loan to be priced early next week
Investors eye 2028, 2031, 2032 as big years for loan maturities
Even leveraged deals still being underwritten, though banks are selective
More articles/Ad
More articles/Ad
More articles
-
Huvepharma, the Bulgarian animal drugs firm, has tightened pricing on its €180m six year term loan ‘B’, in a move that goes against the trend of investor pushback in the leveraged loan market. -
Huvepharma - Orion Engineered Carbons - Delek Group - Emsland – Stärke
-
Two subsidiaries of Materis, the French, Wendel-owned building materials firm, increased margins on €432m of term loan ‘B’s as part of a refinancing, in the first signs of successful push-back from investors after weeks of borrower-friendly terms on new issues.
-
German carbon black producer Orion Engineered Carbons has widened price guidance on its €780m-equivalent loan and will close books on the deal today.
-
Delek Group, the Israeli energy conglomerate, has allocated the €655m loan that backs TDR Capital’s purchase of its petrol station and convenience store operations in Benelux and France.
-
Two leveraged finance bankers, one focused on Spanish corporate origination and one focused on financial sponsors, have left Barclays to join Credit Suisse's leveraged finance and sponsors team.
